IPO registrations (S-1, F-1) · Registrants
NephroGenex, Inc.
- SEC CIK
- 1338095 · filings on EDGAR ↗
- Former names
- NephroGenex Inc (2005–2008)
- Registration
- Form S-1, first filed 2013-12-23, last 2015-07-16; 2 initial registrations, 9 amendments
- Outcome
- Final prospectus filed 2014-02-12; declared effective 2014-02-10
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- P.O. BOX 400, Jamison, PA 18929
- EDGAR entity type
- operating
- Insiders and CEO pay
- NephroGenex, Inc. on the corporate pages
Offering terms
- Proposed price range
- $12.00–$14.00 per share (S-1/A filed 2014-02-03)
- Final price
- $12.00 per share, within the range (424B4 filed 2014-02-12, an initial public offering)
- Shares sold
- 3,100,000
- Gross proceeds
- $37,200,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol NRX
- Lead underwriters
- Aegis Capital
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form D issuer: NephroGenex, Inc. EXACT (CIK (EXACT))
- SEC filer: NephroGenex, Inc. EXACT (CIK (EXACT))
Filings 18
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2013-12-23 | S-1 | S-1 (registration) | NephroGenex, Inc. | 0001571049-13-001292 ↗ |
| 2014-01-10 | S-1/A | S-1/A (amendment) | NephroGenex, Inc. | 0001571049-14-000082 ↗ |
| 2014-01-17 | S-1/A | S-1/A (amendment) | NephroGenex, Inc. | 0001571049-14-000131 ↗ |
| 2014-01-29 | S-1/A | S-1/A (amendment) | NephroGenex, Inc. | 0001571049-14-000268 ↗ |
| 2014-02-03 | S-1/A | S-1/A (amendment) | NephroGenex, Inc. | 0001571049-14-000299 ↗ |
| 2014-02-10 | EFFECT | EFFECT (declared effective) | NephroGenex, Inc. | 9999999995-14-000380 ↗ |
| 2014-02-12 | 424B4 | 424B4 (final prospectus) | NephroGenex, Inc. | 0001571049-14-000390 ↗ |
| 2015-04-20 | S-1 | S-1 (registration) | NephroGenex, Inc. | 0001047469-15-003696 ↗ |
| 2015-04-30 | S-1/A | S-1/A (amendment) | NephroGenex, Inc. | 0001047469-15-004216 ↗ |
| 2015-06-25 | S-1/A | S-1/A (amendment) | NephroGenex, Inc. | 0001047469-15-005756 ↗ |
| 2015-07-07 | S-1/A | S-1/A (amendment) | NephroGenex, Inc. | 0001047469-15-005980 ↗ |
| 2015-07-07 | S-1/A | S-1/A (amendment) | NephroGenex, Inc. | 0001047469-15-005989 ↗ |
| 2015-07-16 | S-1/A | S-1/A (amendment) | NephroGenex, Inc. | 0001047469-15-006150 ↗ |
| 2015-07-16 | S-1MEF | S-1MEF (added securities) | NephroGenex, Inc. | 0001104659-15-051525 ↗ |
| 2015-07-16 | EFFECT | EFFECT (declared effective) | NephroGenex, Inc. | 9999999995-15-001945 ↗ |
| 2015-08-21 | EFFECT | EFFECT (declared effective) | NephroGenex, Inc. | 9999999995-15-002359 ↗ |
| 2015-12-11 | EFFECT | EFFECT (declared effective) | NephroGenex, Inc. | 9999999995-15-003253 ↗ |
| 2015-12-15 | EFFECT | EFFECT (declared effective) | NephroGenex, Inc. | 9999999995-15-003295 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2014-02-03 | S-1/A | registration statement | $12.00–$14.00 | 3,100,000 | - | Nasdaq NRX | 1 | primary document; range, shares headline, cover names 1 | document ↗ | |
| 2014-02-12 | 424B4 | final prospectus | $12.00 | 3,100,000 | $37,200,000 | Nasdaq NRX | 1 | primary document; price sentence, shares headline, proceeds table, cover names 1 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Care Capital III LLC | Director,TenPercentOwner | 2 | 2014 | ||
| Care Capital Investments III L.P. | Director,TenPercentOwner | 2 | 2014 | ||
| Care Capital Offshore Investments III LP | Director,TenPercentOwner | 2 | 2014 | ||
| Fox J. Wesley | Director,Officer; Officer | Pres. & Chief Sci. Officer | 6 | 2014–2015 | |
| Hamill John | Officer | Chief Financial Officer | 6 | 2014–2015 | |
| KAIROUZ HABIB | Director,TenPercentOwner; TenPercentOwner | 3 | 2014–2015 | ||
| Legault Pierre | Director,Officer | Chief Executive Officer | 5 | 2014–2015 | |
| LESCHLY MARK | Director,TenPercentOwner; TenPercentOwner | 3 | 2014–2015 | ||
| Markham Richard J | Director; Director,TenPercentOwner | 4 | 2014–2015 | ||
| Peterson Bob | Officer | VP of Prod. Dev. & Reg Aff's.; VP of Prod. Dev. & Reg. Aff's. | 6 | 2014–2015 | |
| Rho Capital Partners LLC | Director,TenPercentOwner; TenPercentOwner | 3 | 2014–2015 | ||
| Rho Ventures V Affiliates, LLC | Director,TenPercentOwner; TenPercentOwner | 3 | 2014–2015 | ||
| Rho Ventures V, L.P. | Director,TenPercentOwner; TenPercentOwner | 3 | 2014–2015 | ||
| RMV V, L.L.C. | Director,TenPercentOwner; TenPercentOwner | 3 | 2014–2015 | ||
| RUCH JOSHUA | Director,TenPercentOwner; TenPercentOwner | 3 | 2014–2015 | ||
| Seltzer Robert R. | Director; Director,TenPercentOwner | 4 | 2014–2015 | ||
| Steiner Eugen | Director | 4 | 2014–2015 | ||
| VOGELBAUM MARTIN | Director | 3 | 2014 | ||
| Mitchum James P. | Director | 3 | 2014–2015 | ||
| Taglietti Marco | Director | 3 | 2014–2015 | ||
| Patel Jaikrishna | Officer | Chief Medical Officer | 3 | 2015 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2015-11-13 | NephroGenex, Inc. | Pharmaceuticals | $28,500,000 | $5,500,000 | 14 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | NephroGenex, Inc. | NC | Form D private offerings | CIK (EXACT) |
| SEC filer | NephroGenex, Inc. | SEC filers (EDGAR) | CIK (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, PA first:
- COLLAGENEX PHARMACEUTICALS INC PA
- ORAPHARMA INC PA
- VICURON PHARMACEUTICALS INC PA
- INOVIO PHARMACEUTICALS, INC. PA
- ADOLOR CORP PA
- PROTARGA INC PA
- Traws Pharma, Inc. PA
- MADRIGAL PHARMACEUTICALS, INC. PA
- Vitae Pharmaceuticals, Inc PA
- PhaseBio Pharmaceuticals Inc PA
In other datasets, the same topic (Health) in PA:
- Nonprofit: 445 FOUNDATION (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health